1. Seamon KB, Daly JW. Forskolin: A unique diterpene activator of cAMP-generating systems. J Cyclic Nucleotide Res 1981;7:201-24 [review].
2. Wysham DG, Brotherton AF, Heistad DD. Effects of forskolin on cerebral blood flow: Implications for the role of adenylate cyclase. Stroke 1986;17:1299-303.
3. Marone G, Columbo M, Triggiani M, et al. Forskolin inhibits the release of histamine from human basophils and mast cells. Agents Actions 1986;18:96-9.
4. Roger PP, Servais P, Dumont JE. Regulation of dog thyroid epithelial cell cycle by forskolin, an adenylate cyclase activator. Exp Cell Res 1990;172:282-92.
5. Wong S, Mok W, Phaneuf S, et al. Forskolin inhibits platelet-activating factor binding to platelet receptors independently of adenylyl cyclase activation. Eur J Pharmacol 1993;245:55-61.
6. Agarwal KC, Parks RE. Forskolin: A potential antimetastatic agent. Int J Cancer 1983;32:801-4.
7. Caprioli J, Sears M. Forskolin lowers intraocular pressure in rabbits, monkeys and man. Lancet 1983;1:958-60.
8. Badian M, Dabrowski J, Grigoleit HG, et al. Effect of forskolin eyedrops on intraocular pressure in healthy males. Klin Monatsbl Augenheilkd 1984;185:522-6 [in German].
9. Kramer W, Thormann J, Kindler M, Schlepper M. Effects of forskolin on left ventricular function in dilated cardiomyopathy. Arzneimittelforschung 1987;37:364-7.
10. Bauer K, Dietersdorfer F, Sertl K, et al. Pharmacodynamic effects of inhaled dry powder formulations of fenoterol and colforsin in asthma. Clin Pharmacol Ther 1993;43:76-83.
11. Dubey MP, Srimal RC, Nityanand S, Dhawan BN. Pharmacological studies on coleonol, a hypotensive diterpene from Coleus forskohlii. J Ethnopharmacol 1981;3:1–13.
12. Bone K, Morgan M. Clinical Applications of Ayurvedic and Chinese Herbs: Monographs for the Western Herbal Practitioner. Queensland, Australia: Phytotherapy Press, 1996.
